Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,481 | 1,126 | 86.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,850 | 3 | 13.6% |
| Education | $16.96 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $6,000 | 99 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,843 | 138 | $0 (2024) |
| Lilly USA, LLC | $2,390 | 132 | $0 (2024) |
| Novo Nordisk Inc | $2,334 | 126 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,834 | 80 | $0 (2024) |
| Amgen Inc. | $1,077 | 49 | $0 (2024) |
| Mannkind Corporation | $831.13 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $686.03 | 28 | $0 (2023) |
| Merck Sharp & Dohme LLC | $632.70 | 35 | $0 (2022) |
| Dexcom, Inc. | $622.21 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,142 | 137 | Lilly USA, LLC ($397.97) |
| 2023 | $3,561 | 132 | Lilly USA, LLC ($576.63) |
| 2022 | $3,034 | 134 | AstraZeneca Pharmaceuticals LP ($411.97) |
| 2021 | $3,940 | 129 | AbbVie Inc. ($1,559) |
| 2020 | $4,499 | 78 | AbbVie Inc. ($3,058) |
| 2019 | $3,205 | 155 | AstraZeneca Pharmaceuticals LP ($502.92) |
| 2018 | $3,300 | 173 | Novo Nordisk Inc ($539.51) |
| 2017 | $3,666 | 193 | AstraZeneca Pharmaceuticals LP ($548.65) |
All Payment Transactions
1,131 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Cardio-renal | ||||||
| 12/18/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $39.26 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 12/18/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: GALLSTONES | ||||||
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Automated insulin delivery system | ||||||
| 12/09/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/06/2024 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: Biological | ||||||
| 11/12/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: GALLSTONES | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Hyperthyroidism | ||||||
| 11/05/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.35 | General |
| 10/30/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/29/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Bone Health | ||||||
| 10/24/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 966 | 5,434 | $620,430 | $205,459 |
| 2022 | 12 | 941 | 4,844 | $588,470 | $197,544 |
| 2021 | 12 | 936 | 3,817 | $540,889 | $186,116 |
| 2020 | 15 | 968 | 3,207 | $480,190 | $135,698 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 376 | 831 | $289,725 | $87,912 | 30.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 38 | 3,840 | $127,160 | $68,398 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 219 | $65,950 | $15,550 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $63,000 | $11,559 | 18.3% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 59 | 59 | $20,650 | $6,338 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $14,000 | $5,102 | 36.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 77 | 169 | $21,125 | $4,941 | 23.4% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 14 | 15 | $5,850 | $2,058 | 35.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $3,150 | $1,365 | 43.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 67 | $6,700 | $860.28 | 12.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $840.00 | $736.89 | 87.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 55 | 76 | $2,280 | $638.40 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 353 | 784 | $274,400 | $88,201 | 32.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 32 | 3,300 | $112,200 | $56,384 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 195 | $58,500 | $14,967 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 88 | 88 | $66,000 | $13,092 | 19.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 54 | 54 | $18,900 | $6,270 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $14,800 | $5,640 | 38.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 72 | 175 | $19,250 | $5,531 | 28.7% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 24 | 25 | $10,000 | $3,665 | 36.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 26 | 26 | $5,200 | $1,782 | 34.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $1,160 | $1,002 | 86.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 34 | 59 | $5,900 | $796.93 | 13.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 51 | 72 | $2,160 | $213.33 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 363 | 790 | $276,500 | $93,570 | 33.8% |
About Dr. Gregory Dodell, M.D
Dr. Gregory Dodell, M.D is a Internal Medicine healthcare provider based in New York City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1053622449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Dodell, M.D has received a total of $28,348 in payments from pharmaceutical and medical device companies, with $3,142 received in 2024. These payments were reported across 1,131 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($24,481).
As a Medicare-enrolled provider, Dodell has provided services to 3,811 Medicare beneficiaries, totaling 17,302 services with total Medicare billing of $724,817. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location New York City, NY
- Active Since 06/30/2010
- Last Updated 08/04/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053622449
Products in Payments
- SYNTHROID (Drug) $4,555
- FARXIGA (Drug) $2,532
- JARDIANCE (Drug) $1,523
- Ozempic (Drug) $861.87
- AFREZZA (Drug) $831.13
- EVENITY (Biological) $631.15
- MOUNJARO (Drug) $578.53
- JANUVIA (Drug) $552.12
- Omnipod (Device) $538.26
- UBRELVY (Drug) $501.05
- INVOKANA (Drug) $456.21
- Kerendia (Drug) $454.69
- SOLIQUA 100/33 (Biological) $404.51
- TOUJEO (Drug) $400.84
- Vascepa (Drug) $391.98
- NATPARA (Drug) $365.10
- Pogo Automatic Blood Glucose Monitoring System (Device) $365.09
- Saxenda (Drug) $340.76
- Synthroid (Drug) $312.84
- Tirosint (Drug) $309.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York City
Pedro Torres-Jimenez, Md, MD
Internal Medicine — Payments: $362.03
Dr. Evelyn Enriquez, Md, MD
Internal Medicine — Payments: $243.86
Dr. Carol Minnerop
Internal Medicine
Dr. Robert Dickerson, M.d, M.D
Internal Medicine
Hamid Mouallem, Md, MD
Internal Medicine
Dr. Frederica Linick, M.d, M.D
Internal Medicine